ArticleLipids2011

Oral glucosylceramide reduces 2,4-dinitrofluorobenzene induced inflammatory response in mice by reducing TNF-alpha levels and leukocyte infiltration.

Jingjing Duan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.